What’s Going On With Tilray Stock Monday?

Tilray Brands Inc (NASDAQ:TLRY) on Monday announced that Aphria RX GmbH received a trading license in Germany.

What Happened: Tilray’s Aphria has received a trading license that will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals and medical wholesalers throughout Germany.

“This milestone of Aphria RX obtaining both its new cultivation license as well as its trading license further expands Tilray’s leadership in medical cannabis research, cultivation, production and distribution in Germany and once again proves our commitment to be one of the most responsible, trusted and market leading cannabis companies in the world with a …

Full story available on Benzinga.com